AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- Highly lethal cancers received disproportionately less federal funding compared with other cancers that have better survival odds, according to a study by researchers at the National Cancer Institute. An analysis of nine types...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Memes from epidemiologist Katelyn Jetelina, PhD, MPH, advocacy organization Fired but Fighting, and others...
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Many patients taking glucagon-like peptide-1 (GLP-1) receptor agonists...
This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen now.
(MedPage Today) -- The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene therapy, lunsotogene parvec...
